Follow us on TwitterStay in touch with us on Facebook

Uterine Fibroids

Magnetic resonance-guided focused ultrasound—approved by the FDA in 2004—has the potential to completely revolutionize the treatment of uterine fibroids. For the first time, women have the option of choosing a nonsurgical, outpatient method of ablating fibroids that preserves the uterus and enables them to return to normal activity within one or two days.
 
Based on two groundbreaking core technologies, MR-guided focused ultrasound gives physicians the ability to destroy fibroid masses by producing precise amounts of heat and vibration within the body with pinpoint accuracy. And because it uses heat rather than radiation to destroy tissue, it can be used again and again without harmful
side effects.

A Record of Safety and Efficacy

Today, MR-guided focused ultrasound treatment for uterine fibroids is offered at medical centers in 15 states in the United States and in 14 countries around the world. Over 3,000 patients have been treated worldwide, including 370 who are being followed for the FDA. Clinical studies conducted at such world-renowned medical centers as the Mayo Clinic, Brigham and Women’s Hospital, the Lahey Clinic, Johns Hopkins University, and the Weill Medical Center have found that MR-guided focused ultrasound to be a very safe treatment with significantly lower side effects relative to alternative treatments. They have also produced rapid and durable resolution of fibroid symptoms, sometimes within days of treatment.

Where can I get treatment?

Find Out More

For more information on how this revolutionary technology is changing the way uterine fibroids are treated, see our patient support website, www.fibroidrelief.org

Last Updated on Monday, April 11 2011 12:42